MDMA in humans: factors which affect the neuropsychobiological
... estimating MDMA intake. Many regular users state that it is difficult to remember how many ecstasy tablets they have taken over months and years, and this problem can be exacerbated by variations in MDMA strength and purity (Curran 2000; Schifano, 2000; Cole and Sumnall, 2003; Parrott, 2004); althou ...
... estimating MDMA intake. Many regular users state that it is difficult to remember how many ecstasy tablets they have taken over months and years, and this problem can be exacerbated by variations in MDMA strength and purity (Curran 2000; Schifano, 2000; Cole and Sumnall, 2003; Parrott, 2004); althou ...
Synthetic cannabinoids in herbal products
... status, a recent survey [8] suggest that the use of these products has dropped significantly. However, it is still increasingly popular among users who have to undergo regular urine drug screenings as current screening methods do not detect synthetic cannabinoids. This observation wa ...
... status, a recent survey [8] suggest that the use of these products has dropped significantly. However, it is still increasingly popular among users who have to undergo regular urine drug screenings as current screening methods do not detect synthetic cannabinoids. This observation wa ...
A - amphetamine
... COCA - cocaine COCA PASTE - an intermediate product in processing coca leaf into cocaine COCAINE BLUES - depression after extended cocaine use COCHORNIS - marijuana COCKTAIL - cigarette laced with cocaine or crack COCKTAIL - partially smoked marijuana cigareete inserted in regular cigarette COCKTAIL ...
... COCA - cocaine COCA PASTE - an intermediate product in processing coca leaf into cocaine COCAINE BLUES - depression after extended cocaine use COCHORNIS - marijuana COCKTAIL - cigarette laced with cocaine or crack COCKTAIL - partially smoked marijuana cigareete inserted in regular cigarette COCKTAIL ...
Medicinal Cannabis - Victorian Law Reform Commission
... Expectations about implementation............................................................................. 12 A regulator .................................................................................................................. 12 An advisory body........................................ ...
... Expectations about implementation............................................................................. 12 A regulator .................................................................................................................. 12 An advisory body........................................ ...
Our Commitment to Legalizing Marijuana for Adults
... The harms of marijuana use can also manifest in users’ quality of life. In one study, heavy marijuana users reported that the drug impaired several important measures of health and quality of life, including physical and mental health, cognitive abilities, social life, and career status. Marijuana ...
... The harms of marijuana use can also manifest in users’ quality of life. In one study, heavy marijuana users reported that the drug impaired several important measures of health and quality of life, including physical and mental health, cognitive abilities, social life, and career status. Marijuana ...
The Gateway Drug: Marijuana
... AIDS, or nausea caused by cancer chemotherapy. There is, however, no solid evidence that smoking marijuana creates any greater benefits than approved medications (including oral THC) now used to treat these patients, relieve their suffering, or mitigate the side effects of their treatment. Anecdotal ...
... AIDS, or nausea caused by cancer chemotherapy. There is, however, no solid evidence that smoking marijuana creates any greater benefits than approved medications (including oral THC) now used to treat these patients, relieve their suffering, or mitigate the side effects of their treatment. Anecdotal ...
Dronabinol and Marijuana in HIV
... medical marijuana is strong. Recent polls show that 70% to 80% of the American public supports a policy whereby physicians can prescribe marijuana, and 10 states have passed medical marijuana ballot initiatives in opposition to federal policy prohibiting the use of marijuana.7,8 Reasons for smoking ...
... medical marijuana is strong. Recent polls show that 70% to 80% of the American public supports a policy whereby physicians can prescribe marijuana, and 10 states have passed medical marijuana ballot initiatives in opposition to federal policy prohibiting the use of marijuana.7,8 Reasons for smoking ...
Multiple mechanisms involved in the large-spectrum
... Cannabidiol (CBD) is a major phytocannabinoid present in the Cannabis sativa plant. It lacks the psychotomimetic and other psychotropic effects that the main plant compound D9-tetrahydrocannabinol (THC) being able, on the contrary, to antagonize these effects. This property, together with its safety ...
... Cannabidiol (CBD) is a major phytocannabinoid present in the Cannabis sativa plant. It lacks the psychotomimetic and other psychotropic effects that the main plant compound D9-tetrahydrocannabinol (THC) being able, on the contrary, to antagonize these effects. This property, together with its safety ...
An Updated Review of the Research on the Risks and Harms
... 1970s were typically consuming a different drug than today’s users. However, the information that does exist suggests that, on average, marijuana users today are exposed to higher levels of THC than in past decades. Research on potency trends of seized marijuana between 1980 and 1997 concluded that ...
... 1970s were typically consuming a different drug than today’s users. However, the information that does exist suggests that, on average, marijuana users today are exposed to higher levels of THC than in past decades. Research on potency trends of seized marijuana between 1980 and 1997 concluded that ...
Drug-induced psychomimetic effects as a model for psychosis
... the blockade of dopamine receptors within the nigrostriatal system was considered the primary target of (typical) antipsychotic drugs (Seeman, 2002). The first clinical trials with clozapine, which has a wide range of receptor effects including a relatively low affinity for dopamine d c receptors an ...
... the blockade of dopamine receptors within the nigrostriatal system was considered the primary target of (typical) antipsychotic drugs (Seeman, 2002). The first clinical trials with clozapine, which has a wide range of receptor effects including a relatively low affinity for dopamine d c receptors an ...
Cannabis in Australia Use, supply, harms, and responses Monograph series No. 57
... Australia. According to the most recent National Drug Strategy Household Survey, approximately one-third of Australians have tried cannabis, and about one in ten have used it in the past year. Cannabis use is most prevalent among those aged in their 20s, and is more commonly used by males than femal ...
... Australia. According to the most recent National Drug Strategy Household Survey, approximately one-third of Australians have tried cannabis, and about one in ten have used it in the past year. Cannabis use is most prevalent among those aged in their 20s, and is more commonly used by males than femal ...
Discussion paper
... on a user’s health, including risk of addiction, earlier onset or worsening of some mental illnesses in vulnerable individuals, and difficulty thinking, learning, remembering, and making decisions. Such effects may take days, weeks, months or years to resolve after use is stopped, depending on how l ...
... on a user’s health, including risk of addiction, earlier onset or worsening of some mental illnesses in vulnerable individuals, and difficulty thinking, learning, remembering, and making decisions. Such effects may take days, weeks, months or years to resolve after use is stopped, depending on how l ...
Marijuana as a Schedule I Substance: Political Ploy or Accepted
... does not result in a withdrawal syndrome with severe symptomatology."6 4 Dependence on the drug is more likely to be psychological than physical.6 5 b. Behavioral Effects Marijuana has sedative, euphoriant, and, when taken in large doses, hallucinogenic properties.66 At low to moderate doses, clinic ...
... does not result in a withdrawal syndrome with severe symptomatology."6 4 Dependence on the drug is more likely to be psychological than physical.6 5 b. Behavioral Effects Marijuana has sedative, euphoriant, and, when taken in large doses, hallucinogenic properties.66 At low to moderate doses, clinic ...
Outcome expectancy considering the use of alcohol
... sociodemographic data and the usual consumption of the drug. In this MEEQ validation, the psychometric properties found were satisfactory, indicating that the instrument was appropriate for assessing beliefs about the use of cannabis. Aarons et al.25 have assessed the psychometric properties of the ...
... sociodemographic data and the usual consumption of the drug. In this MEEQ validation, the psychometric properties found were satisfactory, indicating that the instrument was appropriate for assessing beliefs about the use of cannabis. Aarons et al.25 have assessed the psychometric properties of the ...
GLOBAL SMART UPDATE - Descentraliza Drogas
... cannabis but rather synthetic cannabinoids which produce cannabis-like effects. Labelled ‘not for human consumption’, these products typically contain dried shredded plant material – which by itself, has no psychoactive properties – that is soaked in or sprayed with one or several synthetic cannabin ...
... cannabis but rather synthetic cannabinoids which produce cannabis-like effects. Labelled ‘not for human consumption’, these products typically contain dried shredded plant material – which by itself, has no psychoactive properties – that is soaked in or sprayed with one or several synthetic cannabin ...
Safety and Side Effects of Cannabidiol, a Cannabis sativa Constituent
... experience anxiety or dissociative symptoms [67] or improved sleep quality, as assessed by standardized rating scales. We did not include in this review studies on cannabis extracts or CBD-rich extracts, as the other several compounds may have multiple interactions with CBD. However, some clinical t ...
... experience anxiety or dissociative symptoms [67] or improved sleep quality, as assessed by standardized rating scales. We did not include in this review studies on cannabis extracts or CBD-rich extracts, as the other several compounds may have multiple interactions with CBD. However, some clinical t ...
Sorting Through the Science on Marijuana: Facts, Fallacies,
... 7. See Michelle Glass et al., Cannabinoid Receptors in the Human Brain: a Detailed Anatomical and Quantitative Autoradiographic Study in the Fetal, Neonatal and Adult Human Brain, 77 NEUROSCIENCE 299, 299–300 (1997) (describing the behavioral effects of cannabinoids, such as “enhancement of the sens ...
... 7. See Michelle Glass et al., Cannabinoid Receptors in the Human Brain: a Detailed Anatomical and Quantitative Autoradiographic Study in the Fetal, Neonatal and Adult Human Brain, 77 NEUROSCIENCE 299, 299–300 (1997) (describing the behavioral effects of cannabinoids, such as “enhancement of the sens ...
Pregnancy, Breast-feeding, and Marijuana
... time generally elapses before effects when marijuana is ingested orally. It is a highly lipophilic substance and hence can be bound to fat stores throughout the body,31 with a tissue half-life of 7 days.30 The active drug is metabolized by the liver.30,31 It is not unusual for heavy chronic users (d ...
... time generally elapses before effects when marijuana is ingested orally. It is a highly lipophilic substance and hence can be bound to fat stores throughout the body,31 with a tissue half-life of 7 days.30 The active drug is metabolized by the liver.30,31 It is not unusual for heavy chronic users (d ...
Marijuana: Respiratory Tract Effects
... Cannabinoid receptors have been isolated in central nervous system tissue of multiple species including rat [45], mouse [46, 47], bovine, feline [48], leech [49], puffer fish [50], and newt [51]. The discovery of endogenous cannabinoids (endocannabinoids) has accelerated research on the cannabinoid ...
... Cannabinoid receptors have been isolated in central nervous system tissue of multiple species including rat [45], mouse [46, 47], bovine, feline [48], leech [49], puffer fish [50], and newt [51]. The discovery of endogenous cannabinoids (endocannabinoids) has accelerated research on the cannabinoid ...
Marijuana - The Children`s Aid Society
... reaction (involving hallucinations and paranoia) in some users, and using mari-‐ juana can worsen the course of illness in patients with schizophrenia. A series of large prospective studies also showed a l ...
... reaction (involving hallucinations and paranoia) in some users, and using mari-‐ juana can worsen the course of illness in patients with schizophrenia. A series of large prospective studies also showed a l ...
Filed - Eastern District of California Blog
... Whether 21 U.S.C. § § 812, Schedule I(c)(10) and (17) must Be Stricken as Violative of the Fifth Amendment’s Equal Protection Clause.. . . . . . . . . . . . . . . . 2 ...
... Whether 21 U.S.C. § § 812, Schedule I(c)(10) and (17) must Be Stricken as Violative of the Fifth Amendment’s Equal Protection Clause.. . . . . . . . . . . . . . . . 2 ...
As High As The Rockies – The Canadian Marijuana Opportunity
... As of the date of this report, there are 30 MMPR licenses held by approximately 21 licensed producers (LPs). Of key importance is that there are over 1300 applicants in line for a license, and it typically can take one to two years to obtain a license. Security clearance is the biggest hurdle, but f ...
... As of the date of this report, there are 30 MMPR licenses held by approximately 21 licensed producers (LPs). Of key importance is that there are over 1300 applicants in line for a license, and it typically can take one to two years to obtain a license. Security clearance is the biggest hurdle, but f ...
cannabis-related shape - Nebraska Council of School Administrators
... Side Effects of Marijuana A 2015 study published by the American Medical Association linked use of cannabinoids to the following side effects: ...
... Side Effects of Marijuana A 2015 study published by the American Medical Association linked use of cannabinoids to the following side effects: ...
Medical cannabis
Medical cannabis, or medical marijuana, refers to the use of cannabis and its cannabinoids to treat disease or improve symptoms. The use of cannabis as a medicine has not been rigorously scientifically tested often due to restrictions on the production of the drug. There is limited evidence suggesting cannabis can be used to reduce nausea and vomiting during chemotherapy, to improve appetite in people with HIV/AIDS, and to treat chronic pain and muscle spasms. Its use for other medical applications is insufficient for conclusions about safety or efficacy.Short-term use increases both minor and major adverse effects. Common side effects include dizziness, feeling tired, vomiting, and hallucinations. Long-term effects of cannabis are not clear. Concerns include memory and cognition problems, risk of addiction, schizophrenia in young people, and the risk of children taking it by accident.The Cannabis plant has a history of medicinal use dating back thousands of years across many cultures. Its current use is controversial. The American Medical Association, the Minnesota Medical Association, the American Society of Addiction Medicine, and other medical organizations have issued statements opposing its use for medicinal purposes. The American Academy of Pediatrics states that while cannabinoids may have potential as therapy for a number of medical conditions, they do not recommend it until more research is done. They, along with the American Medical Association and the Minnesota Medical Association, call for moving cannabis out of DEA Schedule I to facilitate this research.Medical cannabis can be administered using a variety of methods, including vaporizing or smoking dried buds, eating extracts, taking capsules or using oral sprays. Synthetic cannabinoids are available as prescription drugs in some countries; examples include: dronabinol and nabilone. Recreational use of cannabis is illegal in most parts of the world, but the medical use of cannabis is legal in certain countries, including Austria, Canada, Czech Republic, Finland, Germany, Israel, Italy, the Netherlands, Portugal and Spain. In the United States, federal law outlaws all cannabis use, while 20 states and the District of Columbia no longer prosecute individuals for the possession or sale of marijuana, as long as the individuals are in compliance with the state's marijuana sale regulations. However, an appeals court ruled in January 2014 that a 2007 Ninth Circuit ruling remains binding in relation to the ongoing illegality, in federal legislative terms, of Californian cannabis dispensaries, reaffirming the impact of the federal Controlled Substances Act.